Liang EC, Chen C, Lu R, Mannis GN, et al. Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2021;56:3091-3093.
PMID: 34584238